Cambridge Zero Director Professor Emily Shuckburgh takes centre stage at the world's biggest climate event of its kind in New York, talking to global leaders of government, business and philanthropy about Cambridge’s efforts to tackle climate change.

ARIA, the UK’s new R&D funding agency, has announced its line-up of new programme directors – and three of them are current or former researchers from the University of Cambridge.

A healthy lifestyle that involves moderate alcohol consumption, a healthy diet, regular physical activity, healthy sleep and frequent social connection, while avoiding smoking and too much sedentary behaviour, reduces the risk of depression, new research has found.

A near total lack of transparency is making it impossible to assess the quality of corporate-led ecosystem restoration projects, a new study finds.

Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and University College London) and three pharmaceutical companies (AstraZeneca, GSK and Johnson & Johnson Innovation), has secured $226.5 million venture capital financing.